新型无创颅内压监测装置在侵入性颅内压监测患者中的评估:初步结果
本研究在14例接受侵入性颅内压监测的创伤性脑损伤和蛛网膜下腔出血患者中,同步使用基于声学信号分析的无创装置HS-1000进行无创颅内压监测,共获得2543对连续数据点。以≥17 mm Hg为截断值,无创监测的敏感度为0.7541、特异度为0.8887,受试者工作特征曲线下面积为0.895,63%的数据对差值在±3 mm Hg内、85%在±5 mm Hg内。结论认为该无创装置能准确无创测量颅内压,需进一步研究进行临床验证。
要点
- 在14例接受侵入性颅内压监测的患者中,同步采集2543对无创与有创颅内压数据点。
- 以≥17 mm Hg为截断值,无创颅内压监测敏感度0.7541、特异度0.8887,曲线下面积0.895。
- 63%的数据对差值在±3 mm Hg内,85%在±5 mm Hg内,线性回归显示强正相关。
核心结论
- 本研究提供了HS-1000无创颅内压监测仪准确性的首批临床数据,该设备使用先进信号分析算法评估穿过大脑的声学信号特性。
- 研究结果突显了该无创颅内压装置准确无创测量颅内压的能力,进一步研究应聚焦于对颅内压升高值的临床验证。
研究设计与样本
- 研究纳入在神经重症监护室接受治疗的创伤性脑损伤和蛛网膜下腔出血患者,同时使用有创外部脑室引流或脑实质监测作为金标准,以及HS-1000无创装置进行颅内压监测。
- 共收集14例患者的数据,获得2543个连续平行的有创与无创颅内压数据点,每种方法的数据点数量相同。
- 使用MATLAB分析数据,以确定无创与有创颅内压监测测量值之间差异的统计学显著性。
主要发现
- 在任意选择的≥17 mm Hg截断值下,无创颅内压监测的敏感度为0.7541,特异度为0.8887。
- 线性回归分析表明无创与有创颅内压测量值之间存在强正相关关系。
- 无创与有创颅内压之间的差值在63%的数据对读数中位于±3 mm Hg以内,在85%的数据对读数中位于±5 mm Hg以内。
- 受试者工作特征曲线下面积分析显示曲线下面积为0.895,对应无创颅内压监测与有创颅内压监测相比的总体性能。
局限性
- 本研究为初步分析,≥17 mm Hg截断值为任意选择。
- 进一步研究应聚焦于对颅内压升高值的临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE There is no established method of noninvasive intracranial pressure (NI-ICP) monitoring that can serve as an alternative to the gold standards of invasive monitoring with external ventricular drainage or intraparenchymal monitoring. In this study a new method of NI-ICP monitoring performed using algorithms to determine ICP based on acoustic properties of the brain was applied in patients undergoing invasive ICP (I-ICP) monitoring, and the results were analyzed. METHODS In patients with traumatic brain injury and subarachnoid hemorrhage who were undergoing treatment in a neurocritical intensive care unit, the authors recorded ICP using the gold standard method of invasive external ventricular drainage or intraparenchymal monitoring. In addition, the authors simultaneously measured the ICP noninvasively with a device (the HS-1000) that uses advanced signal analysis algorithms for acoustic signals propagating through the cranium. To assess the accuracy of the NI-ICP method, data obtained using both I-ICP and NI-ICP monitoring methods were analyzed with MATLAB to determine the statistical significance of the differences between the ICP measurements obtained using NI-ICP and I-ICP monitoring. RESULTS Data were collected in 14 patients, yielding 2543 data points of continuous parallel ICP values in recordings obtained from I-ICP and NI-ICP. Each of the 2 methods yielded the same number of data points. For measurements at the ≥ 17-mm Hg cutoff, which was arbitrarily chosen for this preliminary analysis, the sensitivity and specificity for the NI-ICP monitoring were found to be 0.7541 and 0.8887, respectively. Linear regression analysis indicated that there was a strong positive relationship between the measurements. Differential pressure between NI-ICP and I-ICP was within ± 3 mm Hg in 63% of data-paired readings and within ± 5 mm Hg in 85% of data-paired readings. The receiver operating characteristic-area under the curve analysis revealed that the area under the curve was 0.895, corresponding to the overall performance of NI-ICP monitoring in comparison with I-ICP monitoring. CONCLUSIONS This study provides the first clinical data on the accuracy of the HS-1000 NI-ICP monitor, which uses advanced signal analysis algorithms to evaluate properties of acoustic signals traveling through the brain in patients undergoing I-ICP monitoring. The findings of this study highlight the capability of this NI-ICP device to accurately measure ICP noninvasively. Further studies should focus on clinical validation for elevated ICP values.
引用
- Ganslandt O, Mourtzoukos S, Stadlbauer A, et al. Evaluation of a novel noninvasive ICP monitoring device in patients undergoing invasive ICP monitoring: preliminary results. J Neurosurg. 2017. PMID: 28784032. doi:10.3171/2016.11.JNS152268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。